Validation and application of a 96-well format solid-phase extraction and liquid chromatography-tandem mass spectrometry method for the quantitation of digoxin in human plasma

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 869, Issue 1-2, 2008, Pages 126-132

  Hashimoto, Yoshitaka ^a   Shibakawa, Kimio ^a   Nakade, Susumu ^a   Miyata, Yasuyuki ^a  

^a ONO PHARMACEUTICAL CO   (Japan)

Author keywords

96 Well SPE; Digoxin; Human plasma; Imidafenacin; LC MS MS

Indexed keywords

CONCENTRATION (PROCESS); EXTRACTION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY;

DIGOXIN; HUMAN PLASMA; IMIDAFENACIN;

PHARMACOKINETICS;

DIGOSIN; DIGOXIN; IMIDAFENACIN;

ACCURACY; ANALYTIC METHOD; ARTICLE; BLOOD SAMPLING; CONCENTRATION (PARAMETERS); DRUG BLOOD LEVEL; DRUG DETERMINATION; ELECTROSPRAY MASS SPECTROMETRY; HUMAN; LIQUID CHROMATOGRAPHY; LOADING DRUG DOSE; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SENSITIVITY AND SPECIFICITY; SOLID PHASE EXTRACTION; STEADY STATE; TANDEM MASS SPECTROMETRY; VALIDATION PROCESS;

ADMINISTRATION, ORAL; ANTI-ARRHYTHMIA AGENTS; CARDIOTONIC AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIGOXIN; HUMANS; IMIDAZOLES; MALE; REPRODUCIBILITY OF RESULTS; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY;

EID: 44749093805     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2008.05.026     Document Type: Article

References (18)

1. Westphal K., Weinbrenner A., Giessmann T., Stuhr M., Franke G., Zschiesche M., Oertel R., Terhaag B., Kroemer H.K., and Siegmund W. Clin. Pharmacol. Ther. 68 (2000) 6
2. Greiner B., Eichelbaum M., Fritz P., Kreichgauer H.P., Richter O.V., Zundler J., and Kroemer H.K. J. Clin. Invest. 104 (1999) 147
3. Ding R., Tayrouz Y., Riedel K.D., Burhenne J., Weiss J., Mikus G., and Haefeli W.E. Clin. Pharmacol. Ther. 76 (2004) 73
4. Verstuyft C., Strabach S., Morabet H.E., Kerb R., Brinkmann U., Dubert L., Jaillon P., Brentano C.F., Trugnan G., and Becquemont L. Clin. Pharmacol. Ther. 73 (2003) 51
5. Toothaker R.D., Corey A.E., Valentine S.N., Agnew J.R., Parekh N., Moehrke W., Thompson G.A., and Powell J.H. J. Clin. Pharmacol. 45 (2005) 773
6. Tankanow R., Tamer H.R., Streetman D.S., Smith S.G., Welton J.L., Annesley T., Aaronson K.D., and Bleske B.E. J. Clin. Pharmacol. 43 (2003) 637
7. Roman D., Bramson C., Ouellet D., Randinitis E., and Gardner M. J. Clin. Pharmacol. 45 (2005) 1407
8. Kothare P.A., Soon D.K., Linnebjerg H., Park S., Chan C., Yeo A., Lim M., Mace K.F., and Wise S.D. J. Clin. Pharmacol. 45 (2005) 1032
9. Feuring M., Lee Y., Orlowski L.H., Michiels N., Smet M.D., Majumdar A.K., Petty K.J., Goldberg M.R., Murphy M.G., Gottesdiener K.M., Hesney M., Brackett L.E., and Wehling M. J. Clin. Pharmacol. 43 (2003) 912
10. Zhou H., Parks V., Patat A., Coz F.L., Simcoe D., and Bradley J.K. J. Clin. Pharmacol. 44 (2004) 1244
11. Dasgupta A. Toxicol. Rev. 25 (2006) 273
12. Dasgupta A., and Reyes M.A. Am. J. Clin. Pathol. 124 (2005) 229
13. Chow L., Johnson M., Wells A., and Dasgupta A. J. Clin. Lab. Anal. 17 (2003) 22
14. Wu S.L., Li W., Wells A., and Dasgupta A. Am. J. Clin. Pathol. 115 (2001) 600
15. Steimer W., Muller C., and Eber B. Clin. Chem. 48 (2002) 507
16. Stone J.A., and Soldin S.J. Clin. Chem. 35 (1989) 1326
17. Yao M., Zhang H., Chong S., Zhu M., and Morrison R.A. J. Pharm. Biomed. Anal. 32 (2003) 1189
18. Guidance for Industry, Bioanalytical Method Validation, US department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), May 2001.